Trial Profile
Multicenter, double-blind, randomized, placebo-controlled study of flexible, titration dose administered on an as needed basis (PRN [pro re nata]) to evaluate the efficacy and the safety of sildenafil for the treatment of erectile dysfunction in male patients on hemodialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Pfizer
- 29 Apr 2008 New trial record.